Commercial exploitation of transgenics

T. J. Smith

doi:10.1016/0734-9750(94)90009-4

Commercial exploitation of transgenics

T. J. Smith

Infectious Disease

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

3 Citations (Scopus)

Abstract

A series of examples of the application of recombinant nucelic acid technology to the production of transgenic organisms is presented. The review considers the distinct advantages of producing certain recombinant biomolecules in appropriate eucaryotic systems rather than in the traditional procaryotic ones. Gene therapy in humans and the production of transgenic animals and plants are discussed. Concerns about the inadvertant construction of new pathogens and ethical considerations about interfereing with poorly understood ecosystems are addressed.

Original language	English
Pages (from-to)	679-686
Number of pages	8
Journal	Biotechnology Advances
Volume	12
Issue number	4
DOIs	https://doi.org/10.1016/0734-9750(94)90009-4
Publication status	Published - 1994

Keywords

Bioreactors
Disease resistance
Gene therapy

Access to Document

10.1016/0734-9750(94)90009-4

Cite this

@article{1a9833e0b82248be9c67decf0fc205a9,

title = "Commercial exploitation of transgenics",

abstract = "A series of examples of the application of recombinant nucelic acid technology to the production of transgenic organisms is presented. The review considers the distinct advantages of producing certain recombinant biomolecules in appropriate eucaryotic systems rather than in the traditional procaryotic ones. Gene therapy in humans and the production of transgenic animals and plants are discussed. Concerns about the inadvertant construction of new pathogens and ethical considerations about interfereing with poorly understood ecosystems are addressed.",

keywords = "Bioreactors, Disease resistance, Gene therapy",

author = "Smith, \{T. J.\}",

year = "1994",

doi = "10.1016/0734-9750(94)90009-4",

language = "English",

volume = "12",

pages = "679--686",

journal = "Biotechnology Advances",

issn = "0734-9750",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Commercial exploitation of transgenics

AU - Smith, T. J.

PY - 1994

Y1 - 1994

N2 - A series of examples of the application of recombinant nucelic acid technology to the production of transgenic organisms is presented. The review considers the distinct advantages of producing certain recombinant biomolecules in appropriate eucaryotic systems rather than in the traditional procaryotic ones. Gene therapy in humans and the production of transgenic animals and plants are discussed. Concerns about the inadvertant construction of new pathogens and ethical considerations about interfereing with poorly understood ecosystems are addressed.

AB - A series of examples of the application of recombinant nucelic acid technology to the production of transgenic organisms is presented. The review considers the distinct advantages of producing certain recombinant biomolecules in appropriate eucaryotic systems rather than in the traditional procaryotic ones. Gene therapy in humans and the production of transgenic animals and plants are discussed. Concerns about the inadvertant construction of new pathogens and ethical considerations about interfereing with poorly understood ecosystems are addressed.

KW - Bioreactors

KW - Disease resistance

KW - Gene therapy

UR - https://www.scopus.com/pages/publications/0028731614

U2 - 10.1016/0734-9750(94)90009-4

DO - 10.1016/0734-9750(94)90009-4

M3 - Article

AN - SCOPUS:0028731614

SN - 0734-9750

VL - 12

SP - 679

EP - 686

JO - Biotechnology Advances

JF - Biotechnology Advances

IS - 4

ER -

Commercial exploitation of transgenics

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this